CADAMURO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 6.104
EU - Europa 2.902
AS - Asia 1.660
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 8
SA - Sud America 7
OC - Oceania 6
Totale 10.699
Nazione #
US - Stati Uniti d'America 6.004
CN - Cina 668
IT - Italia 544
SG - Singapore 499
RU - Federazione Russa 447
IE - Irlanda 439
SE - Svezia 423
DE - Germania 393
HK - Hong Kong 268
UA - Ucraina 248
GB - Regno Unito 162
CA - Canada 97
FI - Finlandia 84
IN - India 52
FR - Francia 38
TR - Turchia 35
ID - Indonesia 30
DK - Danimarca 29
VN - Vietnam 27
JP - Giappone 24
BE - Belgio 17
AT - Austria 16
NL - Olanda 15
EU - Europa 12
TW - Taiwan 11
KR - Corea 10
ES - Italia 9
IR - Iran 9
NO - Norvegia 9
PK - Pakistan 8
CZ - Repubblica Ceca 7
CH - Svizzera 6
IL - Israele 6
PL - Polonia 5
RO - Romania 5
NZ - Nuova Zelanda 4
PH - Filippine 4
BG - Bulgaria 3
BR - Brasile 3
CO - Colombia 3
IQ - Iraq 3
MY - Malesia 3
NG - Nigeria 3
AU - Australia 2
GR - Grecia 2
MX - Messico 2
TN - Tunisia 2
AM - Armenia 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
Totale 10.699
Città #
Ann Arbor 989
Fairfield 568
Woodbridge 545
Chandler 457
Houston 438
Singapore 429
Dublin 424
Ashburn 326
Frankfurt am Main 286
Wilmington 278
Jacksonville 269
Hong Kong 246
Seattle 246
New York 234
Dearborn 224
Cambridge 181
Milan 160
Princeton 145
Nanjing 106
Santa Clara 106
Shanghai 78
Lawrence 55
Beijing 49
Guangzhou 49
Hangzhou 46
Lachine 46
Altamura 37
Boardman 33
Shenyang 32
Helsinki 31
San Diego 31
Jakarta 28
Andover 27
Rome 26
Nanchang 23
Padova 20
Zhengzhou 20
Fremont 19
Ottawa 19
Kunming 18
Los Angeles 18
Pune 18
Brussels 17
Hebei 17
Changsha 16
Toronto 16
Tianjin 15
Mountain View 14
Auburn Hills 12
Dong Ket 12
Jiaxing 12
Jinan 12
London 12
Munich 12
Norwalk 10
Vienna 10
Cinisello Balsamo 9
Hefei 9
Lissone 9
Pisa 9
Redmond 9
Bonndorf 8
Chicago 8
Huizen 8
Kiev 8
New Haven 8
Ningbo 8
Tokyo 8
Washington 8
Appiano Gentile 7
Carate Brianza 7
Oslo 7
Taizhou 7
Assago 6
Brescia 6
Brno 6
Casalserugo 6
Central 6
Edmonton 6
Genoa 6
Monza 6
Udine 6
Xi'an 6
Bergamo 5
Falls Church 5
Foshan 5
Fuzhou 5
Lanzhou 5
Lappeenranta 5
Moscow 5
Saskatoon 5
Shenzhen 5
Tel Aviv 5
Atlanta 4
Auckland 4
Bari 4
Chengdu 4
Dongguan 4
Isola Della Scala 4
Kilburn 4
Totale 7.842
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 465
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 356
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 301
Nephrosphere-Derived Cells are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 294
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 213
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 198
null 197
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 195
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 179
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 177
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 176
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 173
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 172
Cholangiocyte biology as relevant to cystic liver diseases 170
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 170
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 168
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 165
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 161
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 160
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 157
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 156
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 156
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 153
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 148
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 148
Emerging concepts in biliary repair and fibrosis 147
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 146
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 145
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 144
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 143
Animal models of cholestasis: An update on inflammatory cholangiopathies 136
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 134
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 134
The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma 133
Protein kinase a-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis 132
The patient presenting with isolated hyperbilirubinemia 132
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM. 132
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 127
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 124
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C 124
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 122
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 118
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 113
β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis 112
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 111
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 110
Cxcl1 and cxcl10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 110
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 110
The healthy biliary tree: Cellular and immune biology 110
CXCL1 and CXCL10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 108
Role of angiogenesis and angiogenic factors for cholangiocyte growth 107
Notch signaling and progenitor/ductular reaction in steatohepatitis 106
Leukaemia Inhibitory Factor Protects Cholangiocarcinoma Cells From Cytotoxicity Via MCL-1 105
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 100
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 94
Oxidative Stress in Non-Autoimmune Liver Diseases 88
Animal models for cystic fibrosis liver disease (CFLD) 87
Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma 85
The multitasking behavior of cholangiocyte in the reaction to liver damage 82
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 80
Colestasi intraepatica 79
Cirrosi Biliare Primitiva 79
RAC1 and CDC42 activation regulates pdgf‐d mediated caf recruitment by cancer cells in cholangiocarcinoma 79
Animal models of cholangiocarcinoma: What they teach us about the human disease 79
Colangite Sclerosante Primitiva 77
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 71
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts 66
Colestasi Genetiche 66
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 64
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 55
Life without notch: Liver repair in Alagille syndrome 53
Tumor microenvironment and immunology of cholangiocarcinoma 51
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 41
Paracrine platelet-derived growth factor-d (pdgf-d) signaling mediates cancer-associated fibroblast recruitment in cholangiocarcinoma 40
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 39
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis 39
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 38
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 37
Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma 36
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 36
The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit 35
CANCER ASSOCIATED FIBROBLASTS RECRUITMENT IS MEDIATED BY PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALING IN CHOLANGIOCARCINOMA 34
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia 32
Altered Jagged-1/Notch signalling influences liver repair mechanisms in Alagille syndrome 31
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 30
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 29
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis 29
Inhibition of YAP activation induces cell senescence and autophagy while blocking cell proliferation in cholangiocarcinoma (CCA) 29
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 29
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 28
Cholangiocyte biology and pathobiology 26
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 26
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 26
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 25
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 25
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 25
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma 24
Liver Matrix in Benign and Malignant Biliary Tract Disease 24
The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases 22
Cholangiocarcinoma 21
Totale 10.774
Categoria #
all - tutte 43.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.319 0 0 0 151 177 240 259 122 148 81 102 39
2020/20211.335 94 142 139 141 124 86 127 110 119 108 78 67
2021/2022722 52 69 92 45 27 50 31 37 36 67 85 131
2022/20231.670 167 501 166 161 118 240 26 89 100 12 45 45
2023/20242.104 76 70 68 131 351 467 355 103 223 19 39 202
2024/20251.277 275 535 335 132 0 0 0 0 0 0 0 0
Totale 11.271